Sativus Tech Corp.
SATIVUS TECH CORP. is a Delaware-based company focused through its Israeli subsidiary Saffron Tech on developing automated indoor agriculture systems for saffron cultivation. Its business centers on proprietary vertical-farming and remote-management technology designed to grow saffron and related exotic crops in controlled environments.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueAutomated growing containers and indoor cultivation systems for saffron and other crops.
Research, testing, and proof-of-concept development for proprietary cultivation methods.
Pilot and pre-commercial saffron growing activities using vertical farming technology.
Customers
The company’s end users are buyers of saffron and saffron-derived products in food, beauty, wellness, and pharmaceutical applications. Its technology is also relevant to growers or partners seeking turnkey controlled-environment agriculture solutions for high-value crops.
Buy saffron for premium culinary use where consistency, quality, and supply matter.
Buy saffron or saffron-derived inputs for natural cosmetics and wellness products.
Buy saffron for formulations tied to anti-oxidant, anti-depressant, and antiseptic claims.
Evaluate or adopt the company’s automated growing systems and cultivation protocols.
Strategy
Sativus Tech’s strategy is to commercialize a proprietary, fully automated saffron-growing platform that can produce multiple cultivation cycles per year in controlled indoor environments. It is also building proof-of-concept sites and testing protocols to support future scale-up and broader use cases in exotic crops.
A repeatable production system is needed to convert R&D into revenue-generating operations.
Higher-cycle indoor cultivation is intended to improve output and support larger customers.
Development-stage ag-tech businesses require capital before operations become self-funding.
Geography
The company is incorporated in Delaware and operates through Saffron Tech in Israel, where its cultivation pilots and R&D activities are based. Its commercial and technical focus is tied to Israeli agricultural research and controlled-environment growing sites, including the Golan Heights and Ganei Tal.
Risks
The company faces substantial execution and financing risk because its business is still in development and depends on successful commercialization of a new cultivation platform. It also carries typical ag-tech risks around crop performance, technology reliability, scaling, and customer adoption, while its Israeli operating base adds site and regional exposure.
The company states it needs additional capital to continue operations and fund its business plan.
Exposure: Corporate liquidity and continuity of development activities
Auditors included a going-concern explanatory paragraph due to uncertainty over future funding and profitability.
Exposure: Ability to continue as a going concern
Pilot and proof-of-concept systems may not translate into reliable large-scale production.
Exposure: Saffron Tech cultivation platform
Management notes future equity or convertible financing may be dilutive and costly.
Exposure: Existing shareholders
Crop outcomes depend on controlled-environment performance, biological inputs, and site execution.
Exposure: Saffron cultivation cycles and yields
Accounting
Judgemental itemsFinancial statements explicitly note substantial doubt about the company’s ability to continue without new financing.
Impact: May affect asset valuation, liability classification, and investor perception
Revaluations of convertible components are a recurring source of financial income or expense.
Impact: Can materially distort period-to-period earnings and cash flow interpretation
R&D is central to the company’s operating model and is expensed as incurred.
Impact: Directly affects operating loss and reflects development intensity
The company owns a majority stake in Saffron Tech, so ownership changes affect consolidation economics.
Impact: Impacts reported control, equity attribution, and minority interest
Similar listed companies
Publicly listed companies with a comparable business focus.
Raphael Pharmaceutical Inc.
RAPH · Medicinal Chemicals & Botanical Products
Science Applications International Corp
SAIC · Services-Computer Integrated Systems Design
SKYX Platforms Corp.
SKYX · Electric Lighting & Wiring Equipment
Israel Acquisitions Corp
ISLWF · Blank Checks
Israel Acquisitions Corp is a blank check company formed to complete a merger, share exchange, asset acquisition, or similar business combination.
SAB Biotherapeutics, Inc.
SABSW · Biological Products, (No Diagnostic Substances)
Paymentus Holdings, Inc.
PAY · Services-Business Services, NEC
Last updated: 29/04/2026